MAPT and Alzheimer disease: Recently, with the greater range of available antibodies and greater sampling of post-mortem brains, it has been shown that many patients with typical clinical AD features actually have not only the characteristic Aβ and HP-tau deposition in the form of plaques and tangles, respectively, but also additional pathology.